Baxter Ventures

Baxter Ventures is the corporate venture capital arm of Baxter International Inc., a global medical technology company with over 85 years of healthcare innovation history. Founded in 2011 and based in Deerfield, Illinois, the firm invests in companies developing innovative technologies, products, and therapies that advance patient care. Investment areas encompass therapeutic applications complementary to Baxter's presence in critical care, hospital care, nutritional care, renal care, and surgical care, as well as cutting-edge technologies outside the parent's existing product portfolio. The firm targets Series A through later-stage rounds, typically writing checks between $3 million and $25 million, and has made 30 investments across health technology, biotech, pharma, hardware, and software. Portfolio companies include VitalConnect (wearable biosensors), Hospital IQ (hospital operations platform), Medasense (pain monitoring), Covagen (biopharmaceuticals, acquired by Johnson & Johnson), SANIFIT (calcification therapeutics), and ProMedix. Each investment undergoes rigorous evaluation for its potential to address unmet clinical needs and deliver long-term sustainable growth. Baxter Ventures supports founders by connecting them to Baxter International's global distribution channels, clinical development expertise, and commercial infrastructure. Backed by a parent company with approximately $15 billion in annual revenues, portfolio companies gain access to a uniquely scaled corporate partner capable of accelerating market adoption in hospital and clinical settings across the United States and Europe.